Mechanistically, downregulation of pro-SFTPB caused upregulation of phosphoglycerate kinase 1 (PGK1), which led to activation of the Akt signaling pathway, thereby stimulating NSCLC progression. Here, SFTPB is linked to non-small cell lung carcinoma.